Start talking about 3-parent babies and thoughts may turn to science fiction. But, the technology to create a so-called 3-parent baby has been available since the 1990s; it just hasnt been put to use much, or studied.Thats about to change, as the technology has been revived and refined.
The updated technique, called mitochondrial replacement therapy, is being used in conjunction with In vitro fertilization (IVF), both as a way of avoiding some genetic diseases, and a method for ensuring IVF implantation success. The results for the latter havent been promising. However, with little tracking or longterm studies, the repercussions for babies born through this technology are unknown.
Through technology, a 3-parent baby has the DNA of a third person (another woman) added through IVF.
Originally, Dr. Jacques Cohen came up with a cytoplasm transfer in the late 1990s. The procedure used the cytoplasm (the material inside a cell, excluding the nucleus) of a donor egg injected into the host egg, and then fertilized. It produced a zygote that had mitochondrial DNA from the donor and nuclear DNA from the host parents.
According to Nu Sci Mag, Dr. Jacques Cohen reported in his book, Human Preimplantation Embryo Selection, the creation of 17 babies by this procedure, of which one was miscarried, and another was aborted.
The other 15 babies, unfortunately, werent tracked to learn the longterm implications of the DNA mix.
When the FDA [Food and Drug Administration] shut down the practice of cytoplasm transfer in 2001, labeling it a biological product and therefore within their domain, the clinic of Dr. Cohen lost the funding and support to pursue follow-up studies on the 15 other chimeras, Nu Sci reported.
So, while these babies dont exactly have three parents, they do have extra DNA from an additional party besides their host parents. Living things that contain such extra, genetically distinct DNA are known by another name: chimeras.
Chimeras do also occur naturally. A form of chimerism termed tetragametic occasionally (the American Journal of Medical Genetics estimates as many as 8% of fraternal twins have this) occurs when non-identical twins share a blood supply before birth. It can also occur with vanishing twin syndrome, in which one baby is born, but has cells from its now vanished sibling.
Another type of chimerism can happen when a patient receives a blood marrow transplant, then produces blood cells with DNA different from their original DNA. And, mothers often carry cells from the babies they carried, even years after their children are born.
Because chimeras are rare, they remain relatively unstudied. Chimeras born through mitochondrial replacement therapy are even rarer. The implications, both for the health of the baby and the genetic load down the germline, remain mysterious.
One of the justifications for implementing this new, improved fertility technology is to help implantation. Many women undergoing IVF endure two or more expensive and harrowing cycles of it. Ensuring implantation on the first try is a laudable goal.
A new study out of Ukraine suggests it doesnt work so well. There are only two clinics worldwide performing the 3-parent procedure (its currently banned in the US), and the study results, presented at a meeting of the American Society of Reproductive Medicine in Philadelphia, showed only one in 109 procedures led to a baby.
One Zero Medium reported that US experts are negative on the 3-parent baby efficacy for implantation.
Dr. David Keefe, an obstetrician-gynecologist at NYU Langone Health, told One Zero Medium the results are evidence that faulty mitochondria are not to blame for the quality of a womans eggs or infertility. They basically point out that it doesnt work.
Keefe suggests that tried-and-true options, like egg donation and surrogacy, are still the best bets if traditional IVF doesnt work.
The real justification for the procedure might be trying to avoid genetic diseases by adding different DNA into the equation. A baby born through what some US doctors term mitochondrial donation (the procedure was performed in Mexico) was born free of a familial disease called Leigh Syndrome, which always leads to the death of the infant. The family had already lost two children and had suffered four miscarriages because of the disorder.
The result is a baby with 0.1% of their DNA from the donor (mitochondrial DNA) and all the genetic code for things like hair and eye colour from the mother and father, the BBC reported.
Unfortunately, the parents also refused to have their baby tracked. This is problematic, because very little is known about the future health consequences of the procedure.
Mitochondria might be powerful, but theyre also involved in metabolic, immune, neural, and psychiatric function. Earlier this year, researchers published a paper showing that mitochondrial DNA is closely tied to the DNA in the nucleus, meaning it might not be possible to use just any egg donor. A mismatch could cause health problems for the child later in life, Keefe told One Zero Medium.
A recent article in Nature pointed out that scientists, because of lack of tracking and very low sample sizes in existing research, are still in the dark about the impact on babies born from a 3-parent situation.
Scientists dont know what amount of diseased mitochondria would cause noticeable symptoms, or even disease, in a child created using genetic material from two women, Nature reported. But studies in mice have shown that mixtures of mitochondria can result in neurological disorders or metabolic conditions.
Nu Sci MagOne Zero MediumNatureBBCScience Mag
Continued here:
The Reality of 3-Parent Babies - Parentology
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021